Company profile
Causeway Sensors
Causeway Sensors Limited is a UK company with status active founded in 2013 based in Northern Ireland.
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA | Transaction MzUxMzkyNDA4MWFkaXF6a2N4 | Paper/PDF filed
Published 02 Apr 2026 23:32
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
Causeway Sensors develops nanotechnology designed to provide kinetic analysis during biotherapeutic production to improve candidate selection for drug discovery.
Causeway Sensors has developed a truly unique sensing platform, based on optically active nanostructures, with a reader instrument for measuring levels of biological entities. The team has developed a nanostructure surface for sensor chips that has an exceptionally large surface area (increased binding recognition sites) designed for size compatibility with many proteins and bacteria. Our platform will enable the development of state of the art biosensors for use by world leading pharmaceutical and biotech companies for drug discovery, antibody production and disease diagnostics. The technology being chip-based means it would be feasible to integrate with miniaturised electronics, optics and microfluidics to enable high-throughput and low-cost lab-on-a-chip type systems.
Causeway Sensors Ltd has developed novel nanostructured surfaces comprised of nanorods or nanotubes that can be used in a variety of sensing applications. The nature of the nanostructures allows Causeway Sensors to implement a straightforward detection scheme that can be tailored for different markets as diverse as protein bio-sensing through to hazardous gas sensing. Causeway Sensors develops, manufactures and sells a both complete sensing packages, consumable biochips, software and develops solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell and particle studies.
Causeway Sensors was established in November 2013 with initial seed capital totalling €125,000 from angel investors and QUBIS Limited. We subsequently secured EU regional development structural funding (€110,000 from the ERDF) to successfully fund the research and development of our nanostructure surfaces from proof of principle to prototyping stage. In May 2016, Causeway Sensors raised €575k in funding from a UK based VC fund Kernel Capital and a further €25k from QUBIS. The capital is being used to establish the company and further elucidate proof of principle of the technology. Currently 3 of the 4 posts are scientific FTE.
Customers include biology laboratories in academia, Institute laboratories and diverse industry.
1 Apr 2026 to 31 Dec 2026
**Causeway Sensors Limited** is pioneering the next generation of Process Analytical Technology (PAT) to accelerate the development and manufacturing of complex pharmaceuticals, with a specific focus on the emerging **Cell and Gene Therapy (CGT)** market. Our core innovation is a patented, real-time nanophotonic sensor platform integrated with microfluidi...
1 May 2024 to 31 Jul 2025
Downstream processing within the biomanufacturing industry has faced sustained challenges over several decades, driven by increased patient demand for therapeutics and the notable scalability of upstream production. Upstream scalability is achieved by enhancing cell productivity without increasing equipment size or media volume. In contrast, downstream pr...
1 Apr 2024 to 31 Dec 2024
Causeway Sensors is undertaking a project to develop Titan, an advanced sensor platform for integrating into bioreactors that allows real-time monitoring of critical quality attributes in biotherapeutics manufacturing. The Titan system comprises an instrument and a proprietary reagent kit featuring a consumable nanosensor chip for precise and efficient mo...
1 Dec 2021 to 30 Nov 2026
The Smart Nano-Manufacturing Corridor (SNMC) will bring together organisations from across Northern Ireland, using local strengths in Smart and Nano-Manufacturing to create a consortium with over 2000 jobs, providing value add of £220m to the local economy and increasing skill levels in local communities. Companies in Northern Ireland will get access to n...
1 Nov 2017 to 31 May 2021
To develop a novel biosensing chip technology for application in the evaluation of protein-protein interactions.
